Nomura Asset Management CO LTD Mirum Pharmaceuticals, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$33.68 - $44.74 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024
BUY
$23.57 - $34.85 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$24.92 - $30.02 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$27.14 - $34.93 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$24.63 - $32.85 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$23.51 - $30.09 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$19.19 - $24.1 $0 - $0
0 New
0 $0

Others Institutions Holding MIRM

# of Institutions
190
Shares Held
54M
Call Options Held
177K
Put Options Held
167K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.54B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email